Skip to main content

Table 1 Socio-demographic and medical characteristics of patients (n = 104)

From: Assessment of psychosocial factors and distress in women having adjuvant endocrine therapy for breast cancer: the relationship among emotional distress and patient and treatment-related factors

Patient factors

% (n)

Cancer and treatment factors

% (n)

Age [mean (min–max)]

52.49 (32–77)

Time (months) since AET initiation

24.38 (1–58)

Marital status

 

Between 1 and 24 months

49 (51)

 Married

75.9 (79)

Between 25 and 58 months

51 (53)

 Singlea

24 (25)

Current treatment

 

Children

 

Tamoxifenb

47.1 (49)

 One or more

82.7 (86)

Aromatase inhibitors (AIs)c

52.9 (55)

 None

17.3 (18)

Radiotherapy

 

Educational level

 

Yes

71.2 (74)

 Primary or secondary school

33.7 (35)

No

28.8 (30)

 High school

32.7 (34)

Chemotherapy

 

 College or above

33.7 (35)

Yes

61.5 (64)

Socioeconomic status

 

No

38.5 (40)

 Low

17.3 (18)

Pathological tumor stage

 

 Middle

70.2 (73)

T1

40.4 (42)

 High

12.5 (13)

T2

51 (53)

Body mass index (kg/m2)

 

T3

8.7 (9)

 ≤ 24.9

31.7 (33)

Histological grade

 

 25–29.9

40.4 (42)

Grade I

11.5 (12)

 ≥30

27.9 (29)

Grade II

49 (51)

Menopausal status

 

Grade III

39.4 (41)

 Pre-menopausal

46.2 (48)

Type of surgery

 

 Peri or post-menopausal

53.8 (56)

Mastectomy

56.7 (59)

  

Breast conserving surgery

43.3 (45)

  1. aIncludes single, divorced, separated, widower
  2. b2 patients used aromatase inhibitors then switched tamoxifen
  3. cAIs includes anastrozole and letrozole; 4 patients used tamoxifen then switched to AIs